gebhart/patrepeval huggingface dataset:
Spinal fluid lymphocytes from a subgroup of multiple sclerosis patients respond to mycobacterial antigens (1993)

Immune responses to heat shock or stress proteins are observed in several chronic autoimmune diseases. Such proteins are major antigens of many bacteria, especially mycobacteria. To determine whether immune responses to stress proteins occur in chronic inflammatory diseases of the central nervous system such as multiple sclerosis (MS) we measured proliferative responses of lymphocytes from spinal fluids and bloods of patients with MS and other neurological diseases to a sonicate of M. tuberculosis, an acetone extract of M. tuberculosis, a recombinant 65-kd heat shock protein of M. leprae, and tetanus toxoid as a control recall antigen. Significantly increased spinal fluid lymphocyte responses to mycobacterial sonicate, relative to responses from paired peripheral blood lymphocytes, were present in 14 of 20 specimens from patients with MS (p < 0.025) and 2 of 9 specimens from patients with other neurological diseases. Spinal fluid lymphocytes also responded to tetanus toxoid, but differences between blood and spinal fluid were not statistically significant. Lymphocytes from 1 patient with MS responded only to M. leprae. There were no proliferative responses to the M. tuberculosis acetone extract. When patients with MS were classified according to duration of disease (< 2- or > 2-yr duration) 9 of 10 patients with recent onset had cerebrospinal fluid cells that responded to M. tuberculosis compared with 5 of 10 with longer duration symptoms (p < 0.012). Our data suggest a selective recruitment and/or expansion of mycobacterial reactive cells to the central nervous system of a subpopulation of patients with MS.(ABSTRACT TRUNCATED AT 250 WORDS)
Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen (2014)

We conducted a clinical trial of an NY-ESO-1 cancer vaccine using 4 synthetic overlapping long peptides (OLP; peptides #1, 79-108; #2, 100-129; #3, 121-150; and #4, 142-173) that include a highly immunogenic region of the NY-ESO-1 molecule. Nine patients were immunized with 0.25 mg each of three 30-mer and a 32-mer long NY-ESO-1 OLP mixed with 0.2 KE Picibanil OK-432 and 1.25 mL Montanide ISA-51. The primary endpoints of this study were safety and NY-ESO-1 immune responses. Five to 18 injections of the NY-ESO-1 OLP vaccine were well tolerated. Vaccine-related adverse events observed were fever and injection site reaction (grade 1 and 2). Two patients showed stable disease after vaccination. An NY-ESO-1-specific humoral immune response was observed in all patients and an antibody against peptide #3 (121-150) was detected firstly and strongly after vaccination. NY-ESO-1 CD4 and CD8 T-cell responses were elicited in these patients and their epitopes were identified. Using a multifunctional cytokine assay, the number of single or double cytokine-producing cells was increased in NY-ESO-1-specific CD4 and CD8 T cells after vaccination. Multiple cytokine-producing cells were observed in PD-1 (-) and PD-1 (+) CD4 T cells. In conclusion, our study indicated that the NY-ESO-1 OLP vaccine mixed with Picibanil OK-432 and Montanide ISA-51 was well tolerated and elicited NY-ESO-1-specific humoral and CD4 and CD8 T-cell responses in immunized patients.
Aligned arrays of single walled carbon nanotubes for transparent electronics (2013)

Single walled carbon nanotubes have garnered substantial interest in the electronic materials research community due to their unparalleled intrinsic electrical properties. In addition, their mechanical robustness and thin geometries make SWNTs ideal candidates for transparent electronics. Aligned arrays of SWNTs grown via chemical vapor deposition (CVD) on quartz enable device uniformity and wafer scale integration with existing commercial semiconductor processing methods. A crucial roadblock in incorporation of SWNTs in commercial electronics has been the co-existence of metallic and semiconducting SWNTs. Demanding device metrics in high performance and complex integrated electrical devices, sensors, and other applications dictate the necessity of pristine, purely semiconducting arrays of SWNTs. By exploiting a novel process in nanoscale flow of thin film organic coatings, we have demonstrated a method to purify as-grown aligned arrays to produce such as result. Comparison with single nanotube statistics, characterization using a novel thermal scanning probe microscopy technique, as well as corroboration with thermal modeling validated the result. Thin film field effect transistors exhibiting mobilities exceeding ~1000cm<sup>2</sup>/Vs and on/off ratios exceeding 10,000 were fabricated using the purified semiconducting SWNTs. This manuscript reviews some of these results, which represent the first successful demonstration of purification of aligned arrays of SWNTs, in a robust and scalable scheme that allows integration of aligned arrays into complex, high performance electrical devices. We separately also describe new results on the advanced development of soft lithography techniques with the ability to transfer print aligned arrays of SWNTs onto transparent substrates after synthesis and processing, thereby completing a direct pathway to achieve complex, high performance, and highly integrated transparent SWNTs electronics, sensors, or other devices.
Cancer as a metabolic disease (2010)

Emerging evidence indicates that impaired cellular energy metabolism is the defining characteristic of nearly all cancers regardless of cellular or tissue origin. In contrast to normal cells, which derive most of their usable energy from oxidative phosphorylation, most cancer cells become heavily dependent on substrate level phosphorylation to meet energy demands. Evidence is reviewed supporting a general hypothesis that genomic instability and essentially all hallmarks of cancer, including aerobic glycolysis (Warburg effect), can be linked to impaired mitochondrial function and energy metabolism. A view of cancer as primarily a metabolic disease will impact approaches to cancer management and prevention.
Compiling with proofs (1998)

I propose a new compiler architecture for compiling source-level programs into a combination of object code and a proof that the object code preserves certain properties of the source program. Such a certifying compiler is structured as a pipeline of certifying static analyses---analyses that produce an explicit proof of the code properties that they infer---along with certifying code transformations, which transform not only the code but also the input proof to a target proof. The purpose of a certifying compiler is to allow independent and easy verification of the properties of the generated code without the cost of running a program analyzer and without the need to trust such a system. The certifying compiler complements earlier work on Proof-Carrying Code by providing an automatic way to produce the required safety proofs when the safety properties are statically decidable or can be checked at run time. The thesis is that this approach is more practical than approaches based on pro...
Initial formal toxicity evaluation of APC-2, a novel fluorescent tracer agent for real-time measurement of glomerular filtration rate in preparation for a first-in-man clinical trial (2014)

The fluorescent tracer agent 2,5-bis[N-(1-carboxy-2-hydroxy)]carbamoyl-3,6-diaminopyrazine, designated APC-2, has been developed with properties and attributes necessary for use as a direct measure of glomerular filtration rate (GFR). Comparison to known standard exogenous GFR agents in animal models has demonstrated an excellent correlation. A clinical trial to demonstrate this same correlation in humans is in preparation. A battery of formal toxicity tests necessary for regulatory clearance to proceed with a clinical trial has been recently completed on this new fluorescent tracer agent. These include single dose toxicity studies in rats and dogs to determine overall toxicity and toxicokinetics of the compound. Blood compatibility, mutation assay, chromosomal aberration assay, and several other assays were also completed. Toxicity assessments were based on mortality, clinical signs, body weight, food consumption and anatomical pathology. Blood samples were collected to assess pharmacokinetic parameters including half-life, area under the curve, and clearance. Urine samples were collected to assess distribution. Doses of up to 200-300 times the estimated human dose were administered. No test-article related effects were noted on body weight, food consumption, ophthalmic observations and no abnormal pathology was seen in either macroscopic or microscopic evaluations of any organs or tissues. All animals survived to scheduled sacrifice. Transient discoloration of skin and urine was noted at the higher dose levels in both species as expected from a highly fluorescent compound and was not considered pathological. Thus initial toxicology studies of this new fluorescent tracer agent APC-2 have resulted in no demonstrable pathological test article concerns.
Exercise ameliorates high-fat diet-induced metabolic and vascular dysfunction, and increases adipocyte progenitor cell population in brown adipose tissue (2011)

A high-fat diet (HFD) is associated with adipose inflammation, which contributes to key components of metabolic syndrome, including obesity and insulin resistance. The increased visceral adipose tissue mass associated with obesity is the result of hyperplasia and hypertrophy of adipocytes. To investigate the effects of exercise on HFD-induced metabolic disorders, male C57BL/6 mice were divided into four groups: SED (sedentary)-ND (normal diet), EX (exercise)-ND, SED-HFD, and EX-HFD. Exercise was performed on a motorized treadmill at 15 m/min, 40 min/day, and 5 day/wk for 8 wk. Exercise resulted in a decrease in abdominal fat contents and inflammation, improvements in glucose tolerance and insulin resistance, and enhancement of vascular constriction and relaxation responses. Exercise with or without HFD increased putative brown adipocyte progenitor cells in brown adipose tissue compared with groups with the same diet, with an increase in brown adipocyte-specific gene expression in brown and white adipose tissue. Exercise training enhanced in vitro differentiation of the preadipocytes from brown adipose depots into brown adipocytes and enhanced the expression of uncoupling protein 1. These findings suggest that exercise ameliorates high-fat diet-induced metabolic disorders and vascular dysfunction, and increases adipose progenitor cell population in brown adipose tissue, which might thereby contribute to enhanced functional brown adipose.
Use of the Dry Eye Questionnaire to Measure Symptoms of Ocular Irritation in Patients With Aqueous Tear Deficient Dry Eye (2002)

Symptoms of ocular irritation were frequent and intense among SS and KCS subjects. These symptoms often increased in intensity over the day, suggesting that open-eye conditions affect the progression of symptoms. Measurement of symptom frequency and diurnal intensity by the DEQ provides a sensitive tool that may be useful in clinical treatment trials for dry eye.
Scaling question answering to the Web (2001)

Article Scaling question answering to the Web Share on Authors: Cody C. T. Kwok University of Washington, Seattle, WA University of Washington, Seattle, WAView Profile , Oren Etzioni University of Washington, Seattle, WA University of Washington, Seattle, WAView Profile , Daniel S. Weld University of Washington, Seattle, WA University of Washington, Seattle, WAView Profile Authors Info & Claims WWW '01: Proceedings of the 10th international conference on World Wide WebMay 2001 Pages 150–161https://doi.org/10.1145/371920.371973Online:01 April 2001Publication History 159citation1,177DownloadsMetricsTotal Citations159Total Downloads1,177Last 12 Months88Last 6 weeks11 Get Citation AlertsNew Citation Alert added!This alert has been successfully added and will be sent to:You will be notified whenever a record that you have chosen has been cited.To manage your alert preferences, click on the button below.Manage my AlertsNew Citation Alert!Please log in to your account Save to BinderSave to BinderCreate a New BinderNameCancelCreateExport CitationPublisher SiteGet Access
Ferrous iron content of intravenous iron formulations (2016)

The observed biological differences in safety and efficacy of intravenous (IV) iron formulations are attributable to physicochemical differences. In addition to differences in carbohydrate shell, polarographic signatures due to ferric iron [Fe(III)] and ferrous iron [Fe(II)] differ among IV iron formulations. Intravenous iron contains Fe(II) and releases labile iron in the circulation. Fe(II) generates toxic free radicals and reactive oxygen species and binds to bacterial siderophores and other in vivo sequestering agents. To evaluate whether differences in Fe(II) content may account for some observed biological differences between IV iron formulations, samples from multiple lots of various IV iron formulations were dissolved in 12 M concentrated HCl to dissociate and release all iron and then diluted with water to achieve 0.1 M HCl concentration. Fe(II) was then directly measured using ferrozine reagent and ultraviolet spectroscopy at 562 nm. Total iron content was measured by adding an excess of ascorbic acid to reduce Fe(III) to Fe(II), and Fe(II) was then measured by ferrozine assay. The Fe(II) concentration as a proportion of total iron content [Fe(III) + Fe(II)] in different lots of IV iron formulations was as follows: iron gluconate, 1.4 and 1.8 %; ferumoxytol, 0.26 %; ferric carboxymaltose, 1.4 %; iron dextran, 0.8 %; and iron sucrose, 10.2, 15.5, and 11.0 % (average, 12.2 %). The average Fe(II) content in iron sucrose was, therefore, ≥7.5-fold higher than in the other IV iron formulations. Further studies are needed to investigate the relationship between Fe(II) content and increased risk of oxidative stress and infections with iron sucrose.
Changes in Neurodevelopmental Outcomes at 18 to 22 Months' Corrected Age Among Infants of Less Than 25 Weeks' Gestational Age Born in 1993–1999 (2005)

Early childhood neurodevelopmental outcomes among infants of <25 weeks' EGA are not improving in the postsurfactant era, despite more aggressive perinatal and neonatal treatment. Later childhood follow-up assessment is needed to delineate trends in severe cognitive impairment in this extremely high-risk group.
Fundamental Studies of Molybdenum and Tungsten Methylidene and Metallacyclobutane Complexes (2010)

Addition of ethylene to Mo(NAr)(CHCMe2Ph)(OHIPT)(Pyr) (NAr = N-2,6-i-Pr2C6H3, OHIPT = O-2,6-(2,4,6-i-Pr3C6H2)2C6H3, Pyr = NC4H4) led to the trigonal-bipyramidal metallacyclobutane complex Mo(NAr)(C3H6)(OHIPT)(Pyr), in which the imido and aryloxide ligands occupy axial positions. Mo(NAr)(C3H6)(OHIPT)(Pyr) loses ethylene to give isolable Mo(NAr)(CH2)(OHIPT)(Pyr). W(NAr)(CH2)(OTPP)(Me2Pyr) (OTPP = O-2,3,5,6-Ph4C6H, Me2Pyr = 2,5-Me2NC4H2) was prepared similarly. Single-crystal X-ray studies of Mo(NAr)(CH2)(OHIPT)(Pyr) and W(NAr)(CH2)(OTPP)(Me2Pyr) show that they are monomers that contain an η1-pyrrolide ligand and a methylidene ligand in which the M−C−Hanti angle is smaller than the M−C−Hsyn angle, consistent with an agostic interaction between CHanti and the metal. Attempts to prepare analogous Mo(NAd)(CH2)(OHIPT)(Pyr) (Ad = 1-adamantyl) yielded only the ethylene complex Mo(NAd)(C2H4)(OHIPT)(Pyr). W(NArtBu)(CH2)(OTPP)(Me2Pyr) (ArtBu = 2-t-BuC6H4) was isolated upon loss of ethylene from W(NArtBu)(C3H6)(OTPP)(Me2Pyr), but decomposed in solution over a period of several hours at 22 °C. NMR studies of Mo(NAr)(C3H6)(OHIPT)(Pyr) and W(NAr)(C3H6)(OHIPT)(Pyr) species showed them both to be in equilibrium with ethylene/methylidene intermediates before losing ethylene to yield the respective methylidene complexes. Detailed NMR studies of Mo(NAr)(C3H6)(OBitet)(Me2Pyr) (OBitet is the anion derived from (R)-3,3′-dibromo-2′-(tert-butyldimethylsilyloxy)-5,5′,6,6′,7,7′,8,8′-octahydro-1,1′-binaphthyl-2-ol) were carried out and compared with previous studies of W(NAr)(C3H6)(OBitet)(Me2Pyr). It could be shown that Mo(NAr)(C3H6)(OBitet)(Me2Pyr) forms an ethylene/methylidene intermediate at 20 °C at a rate that is 4500 times faster than the rate at which W(NAr)(C3H6)(OBitet)(Me2Pyr) forms an ethylene/methylidene intermediate. It is proposed that the stability of methylidene complexes coupled with their high reactivity accounts for the high efficiency of many olefin metathesis processes that employ monoaryloxidepyrrolide catalysts.
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. (1994)

Interleukin 15 (IL-15) is a novel cytokine that has recently been cloned and expressed. Whereas it has no sequence homology with IL-2, IL-15 interacts with components of the IL-2 receptor (IL-2R). In the present study we performed a functional analysis of recombinant IL-15 on phenotypically and functionally distinct populations of highly purified human natural killer (NK) cells. The CD56bright subset of human NK cells constitutively expresses the high affinity IL-2R and exhibits a brisk proliferative response after the binding of picomolar amounts of IL-2. Using a proliferation assay, IL-15 demonstrated a very steep dose-response curve that was distinct from the dose-response curve for IL-2. The proliferative effects of IL-15 could be abrogated by anti-IL-2R beta (p75), but not by anti-IL-2R alpha (p55). The proliferative effects of IL-2 on CD56bright NK cells could be inhibited by both antibodies. CD56dim NK cells express the intermediate affinity IL-2R in the absence of the high affinity IL-2R. Activation of CD56dim NK cells by IL-15 was similar to that of IL-2 as measured by enhanced NK cytotoxic activity, antibody-dependent cellular cytotoxicity, and NK cell production of interferon gamma, tumor necrosis factor alpha, and granulocyte/macrophage colony-stimulating factor. The IL-15-enhanced NK cytotoxic activity could be completely blocked by anti-IL-2R beta monoclonal antibody. The binding of radiolabeled IL-2 and IL-15 to CD56dim NK cells was inhibited in the presence of anti-IL-2R beta. Scatchard analysis of radiolabeled IL-15 and IL-2 binding to NK-enriched human lymphocytes revealed the presence of high and intermediate affinity receptors for both ligands. IL-15 is a ligand that activates human NK cells through components of the IL-2R in a pattern that is similar but not identical to that of IL-2. Unlike IL-2, IL-15 is produced by activated monocytes/macrophages. The discovery of IL-15 may increase our understanding of how monocytes/macrophages participate in the regulation of NK cell function.
From pertussis to meningococcal disease and back (2011)

From pertussis to meningococcal disease and back represents nearly 30 years of research at Porton, first at the Centre for Applied Microbiology and Research and latterly as part of the Health Protection Agency. I joined the group lead by Andy Robinson developing an acellular pertussis vaccine and was part of an exciting period that encompassed basic antigen characterisation and pathogenesis studies with the development of an acellular vaccine containing fimbriae. Research then changed to focus on serogroup B meningococcal disease, studying the vaccine potential of iron-regulated proteins and then Neisseria lactamica. The resurgence of pertussis seen in some countries alerted me to the lack of understanding of protective immune responses to Bordetella pertussis infection and disease and this is now an active area of research.
340. Synthesis of leprapinic acid and constitution of pinastric acid (1956)

O. P. Mittal and T. R. Seshadri, J. Chem. Soc., 1956, 1734 DOI: 10.1039/JR9560001734
Generation of optical pulses shorter than 0.1 psec by colliding pulse mode locking (1981)

We report a novel passive mode-locking technique in which two synchronized counterpropagating pulses interact in a thin, saturable absorber to produce a short pulse. Continuous stable trains of pulses shorter than 0.1 psec are obtained using a ring laser configuration.
Different regulation of Purkinje cell dendritic development in cerebellar slice cultures by protein kinase Cα and ‐β (2003)

Activity of protein kinase C (PKC), and in particular the PKCgamma-isoform, has been shown to strongly affect and regulate Purkinje cell dendritic development, suggesting an important role for PKC in activity-dependent Purkinje cell maturation. In this study we have analyzed the role of two additional Ca(2+)-dependent PKC isoforms, PKCalpha and -beta, in Purkinje cell survival and dendritic morphology in slice cultures using mice deficient in the respective enzymes. Pharmacological PKC activation strongly reduced basal Purkinje cell dendritic growth in wild-type mice whereas PKC inhibition promoted branching. Purkinje cells from mice deficient in PKCbeta, which is expressed in two splice forms by granule but not Purkinje cells, did not yield measurable morphological differences compared to respective wild-type cells under either experimental condition. In contrast, Purkinje cell dendrites in cultures from PKCalpha-deficient mice were clearly protected from the negative effects on dendritic growth of pharmacological PKC activation and showed an increased branching response to PKC inhibition as compared to wild-type cells. Together with our previous work on the role of PKCgamma, these data support a model predicting that normal Purkinje cell dendritic growth is mainly regulated by the PKCgamma-isoform, which is highly activated by developmental processes. The PKCalpha isoform in this model forms a reserve pool, which only becomes activated upon strong stimulation and then contributes to the limitation of dendritic growth. The PKCbeta isoform appears to not be involved in the signaling cascades regulating Purkinje cell dendritic maturation in cerebellar slice cultures.
Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function (2007)

Engraftment of mesenchymal stem cells (MSCs) derived from adult bone marrow has been proposed as a potential therapeutic approach for postinfarction left ventricular dysfunction. However, limited cell viability after transplantation into the myocardium has restricted its regenerative capacity. In this study, we genetically modified MSCs with an antiapoptotic Bcl-2 gene and evaluated cell survival, engraftment, revascularization, and functional improvement in a rat left anterior descending ligation model via intracardiac injection. Rat MSCs were manipulated to overexpress the Bcl-2 gene. In vitro, the antiapoptotic and paracrine effects were assessed under hypoxic conditions. In vivo, the Bcl-2 gene-modified MSCs (Bcl-2-MSCs) were injected after myocardial infarction. The surviving cells were tracked after transplantation. Capillary density was quantified after 3 weeks. The left ventricular function was evaluated by pressure-volume loops. The Bcl-2 gene protected MSCs against apoptosis. In vitro, Bcl-2 overexpression reduced MSC apoptosis by 32% and enhanced vascular endothelial growth factor secretion by more than 60% under hypoxic conditions. Transplantation with Bcl-2-MSCs increased 2.2-fold, 1.9-fold, and 1.2-fold of the cellular survival at 4 days, 3 weeks, and 6 weeks, respectively, compared with the vector-MSC group. Capillary density in the infarct border zone was 15% higher in Bcl-2-MSC transplanted animals than in vector-MSC treated animals. Furthermore, Bcl-2-MSC transplanted animals had 17% smaller infarct size than vector-MSC treated animals and exhibited functional recovery remarkably. Our current findings support the premise that transplantation of antiapoptotic gene-modified MSCs may have values for mediating substantial functional recovery after acute myocardial infarction.